Pepducin design and use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 9, 2021
Grant Date -
Mar 27, 2014
app pub date -
Apr 9, 2012
filing date -
Apr 8, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
Disclosed here is the rational design and use of potent and specific GPCR antagonist pepducins based on GPCR regions such as the third intracellular loop and adjacent regions.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2012 Application Filing Year
- A61K Class
- 11964 Applications Filed
- 9694 Patents Issued To-Date
- 81.03 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 4 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Aug 9, 2028 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Aug 9, 2032 |
